Skip to content
ClinCalc Pro
Menu
Vitamin B1 (Thiamine) — deficiency treatment / Wernicke's encephalopathy prevention

Thiamine (IV/IM — Pabrinex)

Brand names: Pabrinex IV High Potency

High-potency parenteral vitamin B and C (Pabrinex) given by IV infusion or IM injection to treat or prevent Wernicke's encephalopathy and other acute thiamine deficiency states. This page covers the parenteral replacement used in emergency care.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It supplies thiamine and other B-group vitamins that are essential cofactors for carbohydrate metabolism, replenishing stores rapidly enough to prevent the neurological damage of acute deficiency.

Prescribing in practice

  • Anaphylaxis is the critical risk — give the IV preparation slowly and only where facilities to treat anaphylaxis are immediately available.
  • Administer thiamine before or with any intravenous glucose in at-risk patients, as a glucose load can precipitate Wernicke's encephalopathy.
  • Maintain a low threshold for treatment in alcohol dependence, malnutrition or persistent vomiting, where deficiency is easily missed.

Monitoring

Observe the patient during and after infusion for allergic reactions and monitor for resolution of neurological features.

Counselling the patient

  • Explain this is a vitamin replacement given by drip or injection to protect the brain and nerves.
  • Tell staff at once if you feel itchy, wheezy, light-headed or unwell during the infusion.

Evidence & guidelines

Parenteral thiamine for Wernicke's encephalopathy is supported by national guidance and longstanding clinical experience rather than large randomised trials.

Reference: NICE CG100 Alcohol Dependence; RCP Acute Care Handbook; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.

📚 MRCEM Revision

Featured in these MRCEM clinical pathways

Thiamine (IV/IM — Pabrinex) is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.

MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.